X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (791) 791
Publication (140) 140
Patent (48) 48
Book Review (3) 3
Book Chapter (2) 2
Dissertation (2) 2
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (397) 397
male (250) 250
female (244) 244
middle aged (237) 237
aged (224) 224
hematology (212) 212
adult (195) 195
index medicus (179) 179
oncology (174) 174
aged, 80 and over (133) 133
prognosis (115) 115
treatment outcome (96) 96
rituximab (90) 90
article (63) 63
disease-free survival (63) 63
survival (63) 63
lymphomas (62) 62
survival analysis (62) 62
chemotherapy (58) 58
antineoplastic agents - therapeutic use (56) 56
antineoplastic combined chemotherapy protocols - therapeutic use (54) 54
cancer (54) 54
therapy (54) 54
hemic and lymphatic diseases (49) 49
lymphoma (49) 49
recurrence (47) 47
antibodies, monoclonal - therapeutic use (45) 45
retrospective studies (44) 44
expression (43) 43
multiple myeloma (43) 43
follow-up studies (42) 42
multiple-myeloma (42) 42
survival rate (42) 42
abridged index medicus (41) 41
care and treatment (41) 41
disease progression (41) 41
human necessities (39) 39
hygiene (39) 39
medical or veterinary science (39) 39
preparations for medical, dental, or toilet purposes (39) 39
risk factors (39) 39
non-hodgkins-lymphoma (38) 38
medicine, general & internal (34) 34
multiple myeloma - pathology (34) 34
leukemia (33) 33
multiple myeloma - drug therapy (33) 33
lymphoma, large b-cell, diffuse - drug therapy (32) 32
b-cell lymphoma (31) 31
young adult (30) 30
antibodies, monoclonal, murine-derived (29) 29
flow cytometry (29) 29
prospective studies (29) 29
trial (29) 29
radioimmunotherapy (28) 28
transplantation (28) 28
adolescent (26) 26
follicular lymphoma (26) 26
antineoplastic agents - adverse effects (25) 25
chronic lymphocytic-leukemia (25) 25
research (25) 25
specific therapeutic activity of chemical compounds ormedicinal preparations (25) 25
kaplan-meier estimate (24) 24
thalidomide - analogs & derivatives (24) 24
analysis (23) 23
cohort studies (23) 23
diagnosis (23) 23
drug administration schedule (23) 23
immune system diseases (23) 23
neoplasm staging (23) 23
non-hodgkin lymphoma (23) 23
risk (23) 23
combined modality therapy (22) 22
lymphoma, non-hodgkin - drug therapy (22) 22
multiple myeloma - mortality (22) 22
remission induction (22) 22
thalidomide - therapeutic use (22) 22
time factors (22) 22
bone marrow - pathology (21) 21
thalidomide - administration & dosage (21) 21
thalidomide - adverse effects (21) 21
lymphoid neoplasia (20) 20
lymphoma, b-cell - pathology (20) 20
non-hodgkin's lymphomas (20) 20
phase-ii trial (20) 20
apoptosis (19) 19
cell line, tumor (19) 19
dexamethasone (19) 19
disease (19) 19
elderly-patients (19) 19
lymphoma, b-cell - immunology (19) 19
lymphoma, large b-cell, diffuse - mortality (19) 19
lymphoma, large b-cell, diffuse - pathology (19) 19
mantle cell lymphoma (19) 19
stem-cell transplantation (19) 19
yttrium radioisotopes - therapeutic use (19) 19
anti-cd20 monoclonal-antibody (18) 18
cyclophosphamide (18) 18
dexamethasone - administration & dosage (18) 18
genetic aspects (18) 18
multivariate analysis (18) 18
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (827) 827
French (13) 13
German (8) 8
Spanish (7) 7
Portuguese (3) 3
Chinese (2) 2
Danish (2) 2
Arabic (1) 1
Norwegian (1) 1
Russian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 2019, Volume 133, Issue 24, pp. 2570 - 2574
Mantle cell lymphoma (MCL) is a unique type of non-Hodgkin lymphoma characterized by the overexpression of cyclin D1. MCL patients typically live for years but... 
1ST-LINE TREATMENT | PHASE-II TRIAL | MULTICENTER | SINGLE-AGENT TEMSIROLIMUS | RITUXIMAB | IBRUTINIB | TYROSINE KINASE INHIBITOR | FOLLOW-UP | INVESTIGATORS CHOICE | OPEN-LABEL | HEMATOLOGY
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 26, pp. 3272 - 3278
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2017, Volume 35, Issue 22, pp. 2459 - 2460
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 04/2019, Volume 94, Issue 4, pp. 573 - 576
The issue of physician burnout has received substantial attention in the medical literature and the workplace. Less attention has been paid to prevention.... 
MEDICINE, GENERAL & INTERNAL | Psychological aspects | Social aspects | Physicians | Health aspects | Work-life balance | Insurance industry | Medicine | Work life balance | Hematology | Families & family life | Careers | Outbreaks | Workloads | Lymphomas | Lymphoma | Electronic medical records | Children & youth
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 13, pp. 585 - 585
  Background Hematologic malignancies account for nearly 10% of new cancer diagnoses and cancer deaths in the U.S. The incidence, characteristics, and outcomes... 
Cardiovascular | Internal Medicine | Medicine, Experimental | Medical research | Coronary heart disease | Analysis | Heart attacks | Intubation | Acute coronary syndromes | Angina pectoris
Journal Article
American Journal of Hematology, ISSN 0361-8609, 07/2019, Volume 94, Issue 7, pp. 786 - 793
Predicting early clinical failure in patients with untreated follicular lymphoma (FL) is important but difficult. This study aimed to determine the incidence... 
Medicine, Experimental | Medical research | Pets | Lymphomas | Prognosis | PET imaging
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2019, Volume 94, Issue 3, pp. 291 - 298
Vitreoretinal lymphoma (VRL) management remains a challenge. We present 72 patients with VRL, diagnosed at Mayo Clinic between 1990‐2018. Three nondiffuse... 
B-CELL LYMPHOMA | TREATMENT OUTCOMES | RITUXIMAB | PRIMARY INTRAOCULAR LYMPHOMA | CLINICAL-FEATURES | HEMATOLOGY | ASSOCIATION | CHEMOTHERAPY | INTRAVITREAL METHOTREXATE | RADIATION-THERAPY | CNS LYMPHOMA | Chemotherapy | Dosage and administration | Lymphomas | Methotrexate | Immunotherapy | Cancer
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 07/2019, Volume 37, Issue 21, pp. 1819 - 1819
PURPOSEIn patients with diffuse large B-cell lymphoma (DLBCL), most relapses occur within the first 2 years of diagnosis. We sought to define the rate and... 
TRIAL | RITUXIMAB-CHOP | ONCOLOGY | RISK | CHOP CHEMOTHERAPY | FAILURE | FEATURES
Journal Article
Cancer Research, ISSN 0008-5472, 07/2009, Volume 69, Issue 13, pp. 5522 - 5530
Journal Article
Blood, ISSN 0006-4971, 07/2019
Approximately 10-15% of patients with diffuse large B-cell lymphoma (DLBCL) present with a concurrent indolent lymphoma at initial diagnosis. Their outcomes in... 
Journal Article
Nutrition and Cancer, ISSN 0163-5581, 10/2018, Volume 70, Issue 7, pp. 1088 - 1090
Dietary factors that may reduce the risk of relapse or prolong remission are an area of interest for patients with cancer. There is little data on the role of... 
RISK | NUTRITION & DIETETICS | EVENT-FREE SURVIVAL | ONCOLOGY | Risk reduction | Lymphoma | Fatty acids | Patients | Diet | Lymphocytes B | Medical prognosis | Biomarkers | Remission | Bioindicators | Lymphomas | Cancer | B-cell lymphoma
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 6511 - 6511
Journal Article
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 01/2019, Volume 275, pp. 6 - 12
Journal Article
American Journal of Hematology, ISSN 0361-8609, 12/2018, Volume 93, Issue 12, pp. 1543 - 1550
The impact of physical activity (PA) on lymphoma survival is not known. The association of PA and change in PA with overall (OS), lymphoma‐specific (LSS) and... 
BREAST-CANCER | ADULT SURVIVORS | COLON-CANCER | VITAMIN-D INSUFFICIENCY | NON-HODGKINS-LYMPHOMA | MOLECULAR EPIDEMIOLOGY | SMOKING | QUALITY-OF-LIFE | HEMATOLOGY | EXERCISE | PROGRESSION | Physical fitness | Lymphomas | Exercise
Journal Article
British journal of haematology, ISSN 0007-1048, 08/2019
Ibrutinib-related data in Waldenström macroglobulinaemia (WM) remain sparse, particularly outside of trials. We report on 80 patients [previously treated,... 
Journal Article
Journal Article